{
    "body": "The drug JTV519 is derivative of which group of chemical compounds?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/11429046", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11757794", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21989257", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10683355", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15073377", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12433661", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23349825", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17112502", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22509897", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10789707", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12551874", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12359358", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17313373", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10864882", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11101196"
    ], 
    "ideal_answer": [
        "The 1,4-benzothiazepine derivative JTV-519 is a new type of calcium ion channel modulator.JTV-519, which has potential use as an antiarrhythmic [285800]. The drug is a novel cardioprotectant derivative of 1,4-benzothiazepine for which phase I trials were completed in the third quarter of 1998", 
        "JTV519 (K201), is a 1,4-benzothiazepine derivative and multi-channel blocker, which has been found to stabilize RyR2s and decrease SR Ca\u00b2\u207a leak."
    ], 
    "exact_answer": [
        "1,4-benzothiazepine", 
        "benzothiazepine"
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=chemicals_and_drugs_category", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004339"
    ], 
    "type": "factoid", 
    "id": "54f9b74306d9727f76000004", 
    "snippets": [
        {
            "offsetInBeginSection": 202, 
            "offsetInEndSection": 341, 
            "text": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca\u00b2\u207a leak.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22509897", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 284, 
            "offsetInEndSection": 514, 
            "text": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23349825", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 198, 
            "offsetInEndSection": 491, 
            "text": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21989257", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 186, 
            "text": "K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17313373", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 171, 
            "text": "K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17112502", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 456, 
            "offsetInEndSection": 644, 
            "text": "A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15073377", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 200, 
            "offsetInEndSection": 396, 
            "text": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process. JTV519 is known to have a protective effect against Ca2+ overload-induced myocardial injury.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12551874", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 863, 
            "offsetInEndSection": 1066, 
            "text": "In conclusion, JTV519, a new 1,4-benzothiazepine derivative, corrected the defective channel gating in RyR (increase in both the rapid conformational change and the subsequent Ca(2+) release rate) in HF.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12433661", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 353, 
            "text": "A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12359358", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 66, 
            "offsetInEndSection": 269, 
            "text": "JTV-519, which has potential use as an antiarrhythmic [285800]. The drug is a novel cardioprotectant derivative of 1,4-benzothiazepine for which phase I trials were completed in the third quarter of 1998", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11757794", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 90, 
            "text": "The 1,4-benzothiazepine derivative JTV-519 is a new type of calcium ion channel modulator.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11429046", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 131, 
            "text": "A new 1,4-benzothiazepine derivative, JTV519 (JTV), has strong protective effects against isoproterenol-induced myocardial injury. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11101196", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 102, 
            "text": "A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10864882", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 103, 
            "text": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10789707", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 12, 
            "offsetInEndSection": 139, 
            "text": "A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10683355", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 185, 
            "offsetInEndSection": 289, 
            "text": " We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12551874", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 104, 
            "text": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10789707", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 130, 
            "text": "A new 1,4-benzothiazepine derivative, JTV519 (JTV), has strong protective effects against isoproterenol-induced myocardial injury.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11101196", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 127, 
            "text": "A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10683355", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 175, 
            "offsetInEndSection": 315, 
            "text": " In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca?\u207a leak.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22509897", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 147, 
            "text": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11101196", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 188, 
            "offsetInEndSection": 290, 
            "text": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12551874", 
            "endSection": "abstract"
        }
    ]
}